David Gyorke
Directeur des opérations chez Radiance Therapeutics, Inc.
Profil
David Gyorke is currently the Chief Operating Officer at Radiance Therapeutics, Inc. He previously held positions at Boston Scientific Corp., Cholestech Corp., Chembio Diagnostics, Inc., NeoVista, Inc., Farallon Medical, Inc., and Chembio Diagnostic Systems, Inc. He received his undergraduate degree from California Polytechnic State University.
Postes actifs de David Gyorke
| Sociétés | Poste | Début |
|---|---|---|
Radiance Therapeutics, Inc.
 Radiance Therapeutics, Inc. Medical DistributorsDistribution Services Radiance Therapeutics, Inc. engages in ophthalmic therapeutic innovation, is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery. It specializes in novel anti-metabolite therapy for glaucoma drainage surgery. The company is headquartered in Tucson, AZ. | Directeur des opérations | 01/04/2020 |
Anciens postes connus de David Gyorke
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMBIO DIAGNOSTICS, INC. | Directeur des opérations | 01/04/2020 |
Nanomix, Inc.
 Nanomix, Inc. Medical SpecialtiesHealth Technology Nanomix, Inc. provides nano technology solutions. It is a nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. The firm's nanoscale electronic sensors have enabled the development of the next generation of Point of Care testing systems that can be used in any setting. The company's mobile diagnostic platform performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. Nanomix was founded by Alexander Zettl and Marvin L. Cohen in September 2000 and is headquartered in Emeryville, CA. | Directeur des opérations | 01/01/2016 |
NeoVista, Inc.
 NeoVista, Inc. Medical SpecialtiesHealth Technology NeoVista, Inc. develops device-based therapy for age-related macular degeneration (AMD). The firm's technology utilizes targeted strontium 90 beta radiation in a one-time surgical procedure and this technology has the possibility to reduce the burden that wet AMD places on healthcare providers, patients, and the healthcare system. The company was founded in 2002 and is headquartered in Newark, CA. | Directeur des opérations | 01/01/2011 |
Farallon Medical, Inc.
 Farallon Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Farallon Medical, Inc. provided coagulation-monitoring meters to measure prothrombin time. It also provided test strips for monitoring anticoagulation therapy. The company was founded in 2002 and was headquartered in Hayward, CA. | Directeur des opérations | 01/01/2008 |
Cholestech Corp.
 Cholestech Corp. Medical SpecialtiesHealth Technology Cholestech Corp. provides diagnostic tools and information for risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. It manufactures LDX System, multi-analytic testing system, and accessories to perform individual tests. The company was founded in 1988 and is headquartered in Hayward, CA. | Directeur des opérations | 01/01/2003 |
Formation de David Gyorke
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Entreprise privées | 7 |
|---|---|
Cholestech Corp.
Cholestech Corp. Medical SpecialtiesHealth Technology Cholestech Corp. provides diagnostic tools and information for risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. It manufactures LDX System, multi-analytic testing system, and accessories to perform individual tests. The company was founded in 1988 and is headquartered in Hayward, CA. | Health Technology |
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
NeoVista, Inc.
NeoVista, Inc. Medical SpecialtiesHealth Technology NeoVista, Inc. develops device-based therapy for age-related macular degeneration (AMD). The firm's technology utilizes targeted strontium 90 beta radiation in a one-time surgical procedure and this technology has the possibility to reduce the burden that wet AMD places on healthcare providers, patients, and the healthcare system. The company was founded in 2002 and is headquartered in Newark, CA. | Health Technology |
Nanomix, Inc.
Nanomix, Inc. Medical SpecialtiesHealth Technology Nanomix, Inc. provides nano technology solutions. It is a nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. The firm's nanoscale electronic sensors have enabled the development of the next generation of Point of Care testing systems that can be used in any setting. The company's mobile diagnostic platform performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. Nanomix was founded by Alexander Zettl and Marvin L. Cohen in September 2000 and is headquartered in Emeryville, CA. | Health Technology |
Farallon Medical, Inc.
Farallon Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Farallon Medical, Inc. provided coagulation-monitoring meters to measure prothrombin time. It also provided test strips for monitoring anticoagulation therapy. The company was founded in 2002 and was headquartered in Hayward, CA. | Electronic Technology |
Chembio Diagnostic Systems, Inc.
 Chembio Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
Radiance Therapeutics, Inc.
Radiance Therapeutics, Inc. Medical DistributorsDistribution Services Radiance Therapeutics, Inc. engages in ophthalmic therapeutic innovation, is commercializing a clinically demonstrated novel anti-metabolite therapy for glaucoma drainage surgery. It specializes in novel anti-metabolite therapy for glaucoma drainage surgery. The company is headquartered in Tucson, AZ. | Distribution Services |
